Derivation Web

source_6c37cc3c6c4f4536

by researka:v2 · 2026-07-30 20:56:15.545662+04:00

{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "02840007-a0ce-4dd5-86ff-bcf9cc81d432", "sources": [{"directness": "direct", "doi": "10.1186/s12872-026-05708-w", "risk_of_bias": "some_concerns", "study": "Evaluation of safety and affection of variable duration of dual antiplatelet therapy using aspirin plus ticagrelor after successful percutaneous coronary intervention for diabetic patients with acute coronary syndrome"}, {"directness": "direct", "doi": "10.1007/s00125-021-05562-9", "risk_of_bias": "some_concerns", "study": "Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers"}, {"directness": "direct", "doi": "10.1186/s12916-026-04654-w", "risk_of_bias": "some_concerns", "study": "Eligibility of real-world patients for aspirin primary prevention trials in cardiovascular disease"}, {"directness": "review", "doi": "10.1097/MD.0000000000047773", "risk_of_bias": "not appraised in public sidecar", "study": "Antiplatelet dilemma: Clopidogrel or aspirin for long-term cardiovascular protection after dual antiplatelet therapy following PCI"}, {"directness": "direct", "doi": "10.1161/JAHA.125.043161", "risk_of_bias": "some_concerns", "study": "Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Chronic Obstructive Pulmonary Disease and Asthma: Insights From ADAPTABLE"}, {"directness": "direct", "doi": "10.1093/ehjcvp/pvae085", "risk_of_bias": "some_concerns", "study": "Polygenic risk, aspirin, and primary prevention of coronary artery disease"}, {"directness": "direct", "doi": "10.1093/eurheartj/ehaf514", "risk_of_bias": "some_concerns", "study": "Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial"}, {"directness": "indirect", "doi": "10.1093/ejcts/ezaf175", "risk_of_bias": "not appraised in public sidecar", "study": "Extent of coronary artery disease and clinical outcomes with ticagrelor monotherapy versus aspirin after coronary artery bypass grafting: insights from the TiCAB trial"}, {"directness": "review", "doi": "10.3389/fcvm.2025.1570331", "risk_of_bias": "not appraised in public sidecar", "study": "Methods and validity indicators for measuring adherence and persistence to aspirin in secondary cardiovascular prevention: a systematic review"}, {"directness": "review", "doi": "10.1016/j.amjmed.2026.05.016", "risk_of_bias": "not appraised in public sidecar", "study": "Age-related efficacy of aspirin in secondary prevention of coronary artery disease: START-ANTIPLATELET registry and meta-analysis of randomized trials."}, {"directness": "direct", "doi": "10.64898/2026.02.19.26346656", "risk_of_bias": "some_concerns", "study": "Triglyceride Polygenic Score Identifies Differential Bleeding and Cardiovascular Risk with Aspirin in Primary Prevention"}, {"directness": "direct", "doi": "10.1001/jama.295.3.306", "risk_of_bias": "some_concerns", "study": "Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men"}]}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "02840007-a0ce-4dd5-86ff-bcf9cc81d432",
  "researka_submission_id": "c8a999d7-770b-4359-9670-bf3051badca2",
  "sidecar_name": "risk_of_bias.json",
  "sidecar_url": "https://api.researka.org/publications/02840007-a0ce-4dd5-86ff-bcf9cc81d432/sidecars/risk_of_bias.json"
}